Bristol-Myers profit tops Street view, raises 2018 forecast

Bristol-Myers Squibb Co on Thursday reported a first-quarter profit that exceeded Wall Street estimates on strong demand for its two most important medicines, and the U.S. drugmaker significantly raised its full-year earnings forecast.